Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

10 October 2013: Teachers ‘don’t know enough grammar to teach curriculum’

Many teachers do not have adequate knowledge of English grammar to teach the new curriculum, according to the architect of a government-funded teaching programme. 
More...

8 October 2013: UCL adopts new humanitarian licensing policy to broaden access to essential medicines

UCL makes public its policy, to make a commitment to promote the availability of healthcare-related technologies in developing countries and, through that, broaden access to essential medical care for millions of the world’s most vulnerable people.  
More...

3 October 2013: Meet UCL Mentor Christina and Get Help With Your Marketing

“When I first met Christina, I thought ‘does this woman ever sleep?!’” – Ruth Hou, Business Support Manager. More...

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>